NCT00000227View on ClinicalTrials.gov

Alternate-Day Buprenorphine Administration. Phase VIII - 9

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

August 31, 1994

Conditions

Opioid-Related Disorders

Interventions

DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Vermont

OTHER

NCT00000227 - Alternate-Day Buprenorphine Administration. Phase VIII - 9 | Biotech Hunter | Biotech Hunter